Last Updated:
Access Report
Name Designation Appointment Date Status
Raja Rao Nannamuri

Appointed as Director since January 2006

 Director 09-Jan-2006 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Ravi Shankar Jasti

Appointed as Director since July 1999

 Director 09-Jul-1999 Current
Srinivasa Rao Nannamuri

Appointed as Director since July 1999

 Director 09-Jul-1999 Current

People Timeline

Explore the timeline of key personnel in Symet Drugs Private Limited's leadership journey.

Contact Details
  • Address F No. 102Sri Kalyani K B R Complex Block No.3, S No. 216, Miyapur,Hyderabad - 72. Andhra Pradesh, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code
  • Country India
  • Website -
Frequently Asked Questions
How can I contact Symet Drugs Private Limited?
You can contact Symet Drugs Private Limited through their registered address at F No. 102Sri Kalyani K B R Complex Block No.3, S No. 216, Miyapur,Hyderabad - 72. Andhra Pradesh, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Symet Drugs Private Limited?
The current directors of Symet Drugs Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • RAJA RAO NANNAMURI
  • RAVI SHANKAR JASTI
  • SRINIVASA RAO NANNAMURI
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available